TNF blockade in rheumatoid arthritis: Implications for therapy and pathogenesis (original) (raw)

Special Lectures on the Pathogenesis and the Pathogenesis-based Treatment of Rheumatoid Arthritis. Insights into the pathogenesis of rheumatoid arthritis from application of anti-TNF therapy

Peter Taylor

Japanese Journal of Clinical Immunology, 2000

View PDFchevron_right

Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal

Carlomaurizio Montecucco

Autoimmunity Reviews, 2009

View PDFchevron_right

in Rheumatoid Arthritis Following Anti-TNF-{alpha} Therapy Inhibitors, and Acute-Phase Proteins Regulation of Cytokines, Cytokine

Christian Antoni

View PDFchevron_right

Tumor necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis

Barbara Segal

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2008

View PDFchevron_right

Anti TNF-α Therapy in Rheumatoid Arthritis: A New Insight

Parsha Shanzana

2017

View PDFchevron_right

Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases

Peter Taylor

Current Opinion in Pharmacology, 2010

View PDFchevron_right

TNF? Is an Effective Therapeutic Target for Rheumatoid Arthritis

Ravinder Maini

Annals of the New York Academy of Sciences, 1995

View PDFchevron_right

New approaches to inhibiting TNF production in rheumatoid arthritis: is pathological TNF regulated in the same way as protective TNF?

Ravinder Maini

Arthritis Research Therapy, 2001

View PDFchevron_right

Alternative for Anti-TNF Antibodies for Arthritis Treatment

DAMIEN LOEUILLE

Molecular Therapy, 2011

View PDFchevron_right

Editorial: combination cytokine blockade: the way forward in therapy for rheumatoid arthritis?

Peter Taylor

Arthritis & rheumatology (Hoboken, N.J.), 2015

View PDFchevron_right

Cytokine Blockade as a New Strategy to Treat Rheumatoid Arthritis

David Fox

Archives of Internal Medicine, 2000

View PDFchevron_right

Insights into the pathogenesis of rheumatoid arthritis from applicatin of anti-TNF therapy

peter charles

Japanese Journal of Clinical Immunology, 2000

View PDFchevron_right

Dose reduction of TNF blockers in rheumatoid arthritis: clinical and pharmacological aspects

A. van der Maas

2013

View PDFchevron_right

Anti-cytokine therapy in rheumatoid arthritis

Ravinder Maini

Baillière's clinical rheumatology, 1995

View PDFchevron_right

The role of TNF-α in rheumatoid arthritis: a focus on regulatory T cells

Byron Baron

Journal of Clinical and Translational Research, 2016

View PDFchevron_right

Anti-TNFα therapy in rheumatoid arthritis and autoimmunity

Domenico Biasi

Rheumatology International, 2004

View PDFchevron_right

Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis

Bernhard Heilig

The Clinical Investigator, 1992

View PDFchevron_right

Influence of anti-TNF immunogenicity on safety in rheumatic disease: a narrative review

Daniele Cammelli

Expert Opinion on Drug Safety, 2016

View PDFchevron_right

Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis

Pilar Barrera

Annals of the Rheumatic Diseases, 2001

View PDFchevron_right

The plasma Tumor Necrosis Factor-α (TNF-α) does not have any correlation with disease activity in rheumatoid arthritis patients treated with disease modifying anti-rheumatic drugs (DMARDs)

zahra samimi

Brazilian Journal of Pharmaceutical Sciences, 2020

View PDFchevron_right

Anti-TNF-α treatment in rheumatoid arthritis with anti-Ro/SSA antibodies. Analysis of 17 cases among a cohort of 322 treated patients

Ilaria Cavazzana

Clinical and experimental rheumatology

View PDFchevron_right

Recommendations of the French Society for Rheumatology regarding TNFα antagonist therapy in patients with rheumatoid arthritis

X. Puechal

Joint Bone Spine, 2007

View PDFchevron_right

Regulation of Cytokines, Cytokine Inhibitors, and Acute-Phase Proteins Following Anti-TNF-α Therapy in Rheumatoid Arthritis

Ravinder Maini

The Journal of Immunology

View PDFchevron_right

Lessons learned in the use of tumor necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis

Ted Mikuls

Current rheumatology reports, 2003

View PDFchevron_right

The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice

Tim Jansen

Annals of the Rheumatic Diseases, 2007

View PDFchevron_right

“Are there any evidences for using the intra-articular TNF-α blockade in resistant arthritis?”

ugo fiocco

Joint Bone Spine, 2011

View PDFchevron_right

Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy

Ibrahim Jantan

Biomedicine & Pharmacotherapy, 2017

View PDFchevron_right

Blockade of tumour necrosis factor significantly alters the serum level of IgG- and IgA-rheumatoid factor in patients with rheumatoid arthritis

Bahman Yazdani

Annals of the Rheumatic Diseases, 2005

View PDFchevron_right

Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy

Yukihiko Saeki

Journal of clinical immunology, 1999

View PDFchevron_right

Emerging role of anti-tumor necrosis factor therapy in rheumatic diseases

Beh Ra

Arthritis Research & Therapy, 2002

View PDFchevron_right

Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5 years follow-up

Ahmed Fathy

International Journal of Rheumatic Diseases, 2012

View PDFchevron_right

Evaluation of the role of cytokines in autoimmune disease: the importance of TNF alpha in rheumatoid arthritis

Ravinder Maini

1992

View PDFchevron_right

Anti-TNF-α treatment in rheumatoid arthritis with anti-Ro

Franco Franceschini

2007

View PDFchevron_right

Optimizing outcomes in patients with rheumatoid arthritis and an inadequate response to anti-TNF treatment

Paul Emery

Rheumatology, 2012

View PDFchevron_right

Antibodies to Tumor Necrosis Factors in the Treatment of Rheumatoid Arthritis and Spondyloarthritis: The Basic Science, Clinical Science and Unmet Needs; Results from a Single Center

Sundeep Upadhyaya

Open Journal of Rheumatology and Autoimmune Diseases, 2014

View PDFchevron_right